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The regulation and coordination of mitochondrial
metabolism with hematopoietic stem cell (HSC)
self-renewal and differentiation is not fully under-
stood. Here we report that depletion of PTPMT1,
a PTEN-like mitochondrial phosphatase, in inducible
or hematopoietic-cell-specific knockout mice re-
sulted in hematopoietic failure due to changes in
the cell cycle and a block in the differentiation of
HSCs. Surprisingly, the HSC pool was increased
by 40-fold in PTPMT1 knockout mice. Reintro-
duction of wild-type PTPMT1, but not catalytically
deficient PTPMT1 or truncated PTPMT1 lacking
mitochondrial localization, restored differentiation
capabilities of PTPMT1 knockout HSCs. Further
analyses demonstrated that PTPMT1 deficiency
altered mitochondrial metabolism and that phospha-
tidylinositol phosphate substrates of PTPMT1
directly enhanced fatty-acid-induced activation of
mitochondrial uncoupling protein 2. Intriguingly,
depletion of PTPMT1 from myeloid, T lymphoid, or
B lymphoid progenitors did not cause any defects
in lineage-specific knockout mice. This study estab-
lishes a crucial role of PTPMT1 in themetabolic regu-
lation of HSC function.
INTRODUCTION
Mitochondria are highly dynamic organelles that play multiple
important roles in cells (Balaban et al., 2005). As the site of respi-
ration/oxidative phosphorylation, these double-membrane
organelles provide a highly efficient route for eukaryotic cells to
generate ATP from energy-rich molecules. The role of the mito-
chondria in ATP generation is dependent on ambient oxygen
tension. Under normal oxygen tensions, cells catabolize glucose
to pyruvate. Pyruvate is then imported into the mitochondria for
further catabolism through the Krebs cycle, which transfers elec-
trons to the respiratory chain for ATP synthesis. In low oxygen62 Cell Stem Cell 12, 62–74, January 3, 2013 ª2013 Elsevier Inc.tensions, or hypoxic conditions where there is a lack of oxygen
as an electron acceptor, cells undergo anaerobic glycolysis as
a default mode. Pyruvate is then used for low-efficiency energy
production in the cytosol by glycolysis. Mitochondrial energy
metabolism is regulated by multiple mechanisms. Uncoupling
proteins (UCPs), especially UCP1, in the mitochondrial inner
membrane attenuate mitochondrial energy production by con-
ducting proton leak from the intermembrane space to the matrix
and dissipating the proton gradient necessary for ATP genera-
tion (Brand and Esteves, 2005; Krauss et al., 2005). The functions
of other UCPs, however, are still controversial. Emerging
evidence suggests that UCP2 may regulate cellular bioener-
getics by controlling mitochondrial substrate utilization. Specifi-
cally, increased UCP2 activity inhibits pyruvate entering into the
mitochondria for Krebs cycle utilization while facilitating the
oxidation of alternative carbon sources, such as fatty acids
and glutamine (Bouillaud, 2009; Diano and Horvath, 2012; Sa-
mudio et al., 2009).
The function ofmitochondria in the coordination of hematopoi-
etic stem cell (HSC) maintenance and lineage differentiation is
not well defined (Mantel et al., 2011; Suda et al., 2011). The
ambient oxygen tension in the microenvironment (niches) of
HSCs is believed to be low. To produce ATP in this environment,
HSCs utilize glycolysis instead of mitochondrial oxidative phos-
phorylation for energy production (Simsek et al., 2010). Limited
mitochondrial aerobic metabolism in HSCs helps to preserve
this essential cell reservoir from oxidative damage by attenuating
the production of reactive oxygen species (ROS), a byproduct
generated during mitochondrial oxidative phosphorylation. A
recent study has demonstrated that the mitochondrial content
in HSCs is even slightly higher than that in myeloid progenitors,
although lower than that in late erythroid progenitors (Norddahl
et al., 2011), indicating that mitochondria in HSCs are relatively
inactive. However, when HSCs undergo differentiation, a robust
energy demand is expected for this rapid and energy-consuming
cellular process. Indeed, ATP and ROS levels in lineage-
committed progenitors are much higher than those in HSCs
(Inoue et al., 2010; Simsek et al., 2010). Nonetheless, how mito-
chondrial energymetabolism is regulated and howmitochondrial
bioenergetics and substrate utilization cooperatively coordinate
both HSC differentiation and self-renewal in concert with other
mechanisms is poorly understood.
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is relatively widely expressed in various tissues and is exclusively
localized to the inner membrane of mitochondria via N-terminal
amino acids 1–37 (Pagliarini et al., 2005). Little is known about
the role of PTPMT1 in physiology and disease; however, recent
studies have shown that global disruption of PTPMT1 results in
developmental arrest and postimplantation lethality (Shen
et al., 2011; Zhang et al., 2011a) due to the block of embryonic
stem cell (ESC) differentiation (Shen et al., 2011). To further
dissect the physiological function of PTPMT1, we have created
a PTPMT1 conditional allele (PTPMT1fl/+) and determined
the effects of PTPMT1 depletion on hematopoietic cell
development.
RESULTS
PTPMT1 Depletion Results in Hematopoietic Failure
While the StemCell Pool Is Drastically Expanded in Adult
PTPMT1 Conditional Knockout Mice
PTPMT1 is highly expressed in HSCs (LineageSca-1+c-Kit+
CD150+CD48Flk2), LSK (LineageSca-1+c-Kit+) cells, and
LK (LineageSca-1c-Kit+) cells relative to Lineage+ and mature
cells (Figure 1A). To dissect the role of PTPMT1 in hematopoi-
esis, we created a PTPMT1 conditional allele (PTPMT1fl/+)
(Figures S1A–S1C available online) and generated PTPMT1fl/fl/
Mx1-Cre+ mice based on PTPMT1fl/+ mice and Mx1-Cre trans-
genic mice that express Cre in panhematopoietic cells (including
HSCs) in response to polyinosinic-polycytidylic acid (pI-pC)
treatment (Ku¨hn et al., 1995). Four-week-old PTPMT1fl/fl/Mx1-
Cre+ mice were treated with pI-pC to induce Cre expression
and PTPMT1 deletion. As a result, nearly 80% of the mice died
within 2–3 weeks of treatment (Figure 1B) due to pancytopenia
and severe anemia (Figure S1D). Moreover, bone marrow (BM)
myeloid (Figure 1C) and lymphoid (Figure 1D) progenitors de-
tected by colony-forming unit (CFU) assays were drastically
decreased as compared with those in control mice. Twenty
percent of pI-pC-treated PTPMT1fl/fl/Mx1-Cre+ mice survived
owing to the incomplete deletion of PTPMT1 in HSCs and the
reconstitution of hematopoiesis from PTPMT1-undeleted
HSCs. As shown in Figure 1E, 7 days after pI-pC treatment,
a majority of peripheral blood cells showed PTPMT1 deletion
(representing direct deletion from these cells). However, 3 weeks
later, PTPMT1 deletion in peripheral blood cells was greatly
decreased in surviving PTPMT1fl/fl/Mx1-Cre+ mice. Quantitative
reverse transcription PCR (RT-PCR) analyses revealed that in
these surviving animals PTPMT1 was deleted in 95%–98% of
HSCs and LSK cells, whereas PTPMT1 deletion in common
myeloid progenitors (CMPs; LineageSca-1c-Kit+CD34+
CD16/32low) and Lineage+ cells was only 20% (Figure 1F).
Surprisingly, the percentage of HSCs in the BM of these mice
was increased by 40-fold (Figure 1G) (absolute numbers are
shown in Table S1) despite PTPMT1 deletion in 95%–98% of
these cells, indicative of a robust expansion/accumulation
of knockout stem cells. Phenotypic multipotent progenitor
(MPP) cell populations (LineageSca-1+c-Kit+CD150CD48
Flk2, LineageSca-1+c-Kit+CD150+CD48+Flk2, Lineage
Sca-1+c-Kit+CD150CD48+Flk2, and LineageSca-1+c-Kit+
CD150CD48+Flk2+) (Kiel et al., 2005; Wilson et al., 2008) were
increased by 2.8- to 11-fold (Figure 1G). Remarkably, even12 months after PTPMT1 ablation, the number of HSCs (90%
of which exhibited PTPMT1 depletion) in the knockout mice
were still27 times greater than that in control mice (Figure S1E).
The drastic expansion of the stem cell pool implies that hemato-
poietic failure caused by PTPMT1 ablation from the mitochon-
dria was not due to an induction of apoptosis. In fact, apoptotic
cells in HSCs were not appreciably changed in PTPMT1
knockout mice (Figure 1H).
Hematopoietic-Cell-Specific PTPMT1 Knockout Mice
Fail to Establish Postnatal Hematopoiesis
To further verify the crucial role of PTPMT1 in hematopoiesis
observed in inducible PTPMT1 knockout mice, we generated
hematopoietic-cell-specific knockout (PTPMT1fl/fl/Vav1-Cre+)
mice based on PTPMT1fl/+ mice and Vav1-Cre transgenic
mice, in which Cre expression, and thus PTPMT1 deletion, was
restricted to hematopoietic cells including stem cells. All
PTPMT1fl/fl/Vav1-Cre+ mice died of pancytopenia and severe
anemia within 5–9 days of birth (Figure 2A). These animals could
be completely rescued by receiving transplants of wild-type (WT)
BM cells (Figure 2A), verifying the cell-autonomous effect of
PTPMT1 deficiency on neonatal hematopoiesis. Autopsies of
PTPMT1fl/fl/Vav1-Cre+ pups revealed that the sizes of the spleen
and the thymuswere drastically decreased compared with those
of WT littermates (Figure 2B). Histopathological examination of
BM cells confirmed hematopoietic failure (Figure 2C). Total cell
numbers of the BM from PTPMT1fl/fl/Vav1-Cre+ neonates were
decreased by 75-fold at postnatal day 5 (P5) (Figure S2A).
Hematopoietic progenitors in the BM of knockout mice were
undetectable (Figure 2D). The percentage of HSCs [Linea-
geSca-1+CD150+CD48Flk2 cells were quantified because
of the loss of c-Kit expression associated with severe hemato-
poietic failure (Simonnet et al., 2009; Yuan et al., 2004) in
PTPMT1fl/fl/Vav1-Cre+ mice] in the BM of PTPMT1fl/fl/Vav1-
Cre+ mice, however, was increased by 30-fold (Figure 2E;
PTPMT1was completely deleted in these cells; data not shown),
fully consistent with the stem cell effects in inducible adult
PTPMT1 knockouts (Figure 1G). The expansion of HSCs in
PTPMT1fl/fl/Vav1-Cre+mice appeared to be developed gradually
(Figure S2B). Notably, apoptosis in the BM cells (Figure S2C) and
levels of ROS (Figure S2D) that are often elevated and cause cell
death when mitochondria are dysfunctional were not altered.
Differentiation and Repopulating Capabilities of HSCs
Are Blocked in the Absence of PTPMT1
Since HSCs were drastically expanded and MPPs were
increased to a much lesser extent, hematopoietic failure in
PTPMT1 knockout mice appeared to be caused mainly by
a block in the differentiation of stem cells. To test this hypothesis,
HSCs were purified from PTPMT1-depleted mice and assessed
for various functional activities. In response to cytokine stimula-
tion, PTPMT1 knockout stem cells failed to differentiate to
produce colonies in CFU assays (Figure 3A). The capability of
PTPMT1-depleted HSCs to give rise to Lineage+ progeny
when cocultured with OP9 stromal cells was essentially lost (Fig-
ure S3A). We also isolated HSCs and performed single-cell
culture. In contrast to WT stem cells that vigorously differenti-
ated, PTPMT1 knockout stem cells either did not divide or, at
most, underwent one round of cell division under the in vitroCell Stem Cell 12, 62–74, January 3, 2013 ª2013 Elsevier Inc. 63
Figure 1. PTPMT1Depletion Results in Hematopoietic Failure While the StemCell Pool Is Drastically Expanded in Adult PTPMT1Conditional
Knockout Mice
(A) HSC (LineageSca-1+c-Kit+CD150+CD48Flk2), LSK (LineageSca-1+c-Kit+), LK (LineageSca-1c-Kit+), and Lineage+ cells were sorted from mouse BM
cells (n = 3/group). Macrophages were generated from BM cells as described in the Supplemental Information. Total RNA was extracted and PTPMT1 mRNA
levels were determined by quantitative reverse transcription PCR (RT-PCR).
(B) Four-week-old PTPMT1fl/fl/Mx1-Cre+ and PTPMT1+/+/Mx1-Cre+ littermates (n = 30/group) were treated by intraperitoneal injection of pI-pC. Animal survival
rates were determined.
(C and D) BM cells were harvested from PTPMT1fl/fl/Mx1-Cre+ and PTPMT1+/+/Mx1-Cre+ mice (n = 5/group) 2 weeks after pI-pC treatment and assessed for
myeloid (C) and B lymphoid (D) progenitors by CFU assays.
(E) Peripheral blood was collected from PTPMT1fl/fl/Mx1-Cre+ and PTPMT1+/+/Mx1-Cre+mice 1 and 4 weeks after pI-pC treatment. Genomic DNAwas extracted
from white blood cells and subjected to PCR genotyping.
(F) BM cells were harvested from PTPMT1fl/fl/Mx1-Cre+ and PTPMT1+/+/Mx1-Cre+mice (n = 3/group) 4 weeks following pI-pC treatment. HSCs, LSK cells, CMPs
(LineageSca-1c-Kit+CD34+CD16/32low), and Lineage+ cells were isolated. Total RNA was extracted and PTPMT1 mRNA levels were determined by quanti-
tative RT-PCR.
(G and H) BM cells freshly harvested from PTPMT1fl/fl/Mx1-Cre+ and PTPMT1+/+/Mx1-Cre+ littermates 4 weeks following pI-pC treatment were assayed by
multiparameter FACS analyses to determine frequencies of HSCs and MPPs (LineageSca-1+c-Kit+CD150CD48Flk2, LineageSca-1+c-Kit+CD150+
CD48+Flk2, LineageSca-1+c-Kit+CD150CD48+Flk2, and LineageSca-1+c-Kit+CD150CD48+Flk2+) (n = 9/group) (G), and frequencies of early (Annexin
V+/7-AAD) and late (Annexin V+/7-AAD+) apoptotic cells in HSCs (n = 5/group) (H).
Data shown in (A), (C), (D), and (F)–(H) are presented as mean ± SD. Also see Figure S1.
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Figure 2. Hematopoietic-Cell-Specific PTPMT1 Knockout Mice Fail to Establish Postnatal Hematopoiesis
(A) Survival rates of PTPMT1fl/fl/Vav1-Cre+ (n = 50), PTPMT1+/+/Vav1-Cre+ (n = 50), and PTPMT1fl/fl/Vav1-Cre+ (n = 12) mice transplanted with WT BM cells were
determined. Newborn PTPMT1fl/fl/Vav1-Cre+ pups were transplanted with BM cells (1 3 105) from WT pups by intravenous (superficial temporal vein) injection.
(B) Postnatal day 5 (P5) PTPMT1fl/fl/Vav1-Cre+ and PTPMT1+/+/Vav1-Cre+ neonates were dissected and photographed. Spleens dissected from P1 and P5 pups
are shown on the right panel.
(C) Femurs isolated from P5 PTPMT1fl/fl/Vav1-Cre+ and PTPMT1+/+/Vav1-Cre+ pups were processed for histopathological examination (hematoxylin and eosin
staining).
(D) BM cells harvested from P3 PTPMT1fl/fl/Vav1-Cre+ and PTPMT1+/+/Vav1-Cre+ littermates (n = 5/group) were assessed by CFU assays to determine myeloid
progenitors.
(E) BM cells harvested from P3 to P5 PTPMT1fl/fl/Vav1-Cre+ and PTPMT1+/+/Vav1-Cre+ littermates (n = 8/group) were assayed by multiparameter FACS analyses
to determine the frequency of LineageSca-1+CD150+CD48Flk2 cells.
Data shown in (D) and (E) are presented as mean ± SD. Also see Figure S2.
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of PTPMT1 deficiency on stem cell function, competitive
repopulation assays were performed. BM cells (test cells) iso-
lated from PTPMT1fl/fl/Mx1-Cre+ and PTPMT1+/+/Mx1-Cre+
mice (CD45.2+) were mixed with BM cells (competitor cells)
harvested fromBoyJmice (CD45.1+) at the ratio of 1:1 and trans-
planted into lethally irradiated BoyJ mice. Six weeks after trans-
plantation when donor cells were fully engrafted, recipient mice
were treated with pI-pC. In this competitive setting, reconstitu-
tion from PTPMT1-depleted test cells was greatly decreased in
primary transplants (Figures 3C and 3D) and barely detectablein secondary transplants (Figure 3E). The same results were ob-
tained when BM cells from pI-pC-treated PTPMT1fl/fl/Mx1-Cre+
or PTPMT1+/+/Mx1-Cre+ mice were used for competitive trans-
plantations. Contributions of PTPMT1-depleted donor cells to
the whole hematopoietic cell population or each lineage in
primary transplants (Figures S3B and S3C) and secondary trans-
plants (Figure S3D) were blocked. We sorted test-cell-derived
LSK (CD45.2+LSK), myeloid (CD45.2+Mac-1+Gr-1+), B lymphoid
(CD45.2+B220+), and T lymphoid (CD45.2+CD3+) cells from
primary recipients 20 weeks after pI-pC administration and
examinedPTPMT1 deletion in these cells. As shown in Figure 3F,Cell Stem Cell 12, 62–74, January 3, 2013 ª2013 Elsevier Inc. 65
Figure 3. Repopulating Capabilities of PTPMT1-Depleted HSCs Are Blocked
(A) HSCs were sorted from PTPMT1fl/fl/Mx1-Cre+ and PTPMT1+/+/Mx1-Cre+ mice (n = 3/group) 4 weeks after pI-pC treatment and assessed by the CFU assay.
Colonies were counted 12 days later.
(B) Sorted HSCs were individually deposited into 96-well plates and cultured in Thrombopoietin (TPO) (50 ng/ml), Flt3 ligand (50 ng/ml), stem cell factor (SCF)
(50 ng/ml), IL-3 (25 ng/ml), and IL-6 (20 ng/ml) containing medium for 7 days. The numbers of the wells containing 1, 2, or confluent cells were documented.
Representative data from three independent experiments are shown.
(C andD) BMcells (13 106) (test cells) harvested fromPTPMT1fl/fl/Mx1-Cre+ andPTPMT1+/+/Mx1-Cre+mice (CD45.2+) (without pI-pC treatment) weremixedwith
the same number of BoyJ (CD45.1+) BM cells and transplanted into lethally irradiated BoyJ recipients (n = 9/group). Six weeks following transplantation, recipient
mice were treated with pI-pC. Test cell reconstitution (CD45.2+ cells) in peripheral blood and BM cells was determined by FACS analyses 4, 8, 12, 16, and
20 weeks after pI-pC treatment. Representative FACS data are shown in (C) with summarized data shown in (D).
(E) BM cells harvested from primary recipients 20 weeks after pI-pC administration were transplanted into lethally irradiated secondary BoyJ recipient mice (23
106 cells/mouse) (n = 7/group). Test cell reconstitution in peripheral blood was determined 4, 8, 12, and 16 weeks after transplantation.
(F) CD45.2+LSK, CD45.2+Mac-1+Gr-1+, CD45.2+B220+, and CD45.2+CD3+ cells were sorted from the BM of primary transplants (n = 3/group). Total RNA was
extracted and PTPMT1 mRNA levels were determined by quantitative RT-PCR.
(G) Frequencies of LSK cells in the test-cell-derived (CD45.2+) cell populations in primary recipient mice (n = 5/group) were quantified by multiparameter FACS
analyses 20 weeks following pI-pC treatment.
Data shown in (A) and (C)–(G) are presented as mean ± SD. Also see Figure S3.
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Figure 4. Catalytic Activity and Mitochon-
drial Localization Are Required for PTPMT1
Function in HSCs
(A) BM cells freshly harvested from PTPMT1fl/fl/
Mx1-Cre+ mice (without pI-pC treatment) were
transduced with WT PTPMT1, PTPMT1 C132S,
PTPMT1 D37, and control vector through retro-
viral-mediated gene transfer. Transduced cells
were sorted by FACS based on the expression of
the GFP marker contained in the retroviral vector
(MSCV-IRES-GFP). Sorted cells (test cells) were
transplanted with the same number of the BM cells
(competitor cells) isolated fromBoyJmice that had
undergone the same culture procedures into
lethally irradiated BoyJ recipients (n = 10/group).
Six weeks after transplantation, recipient animals were treated with pI-pC. Test cell reconstitution was determined 16 weeks after the last dose of pI-pC.
(B) Embryonic day 15.5 (E.15.5) fetal liver cells freshly harvested from PTPMT1fl/fl/Vav1-Cre+ embryos were transduced with WT PTPMT1, PTPMT1 C132S,
PTPMT1 D37, and vector control. Transduced cells (1 3 106 cells with around 20% transduction efficiency) were transplanted into lethally irradiated BoyJ
recipients. Survival curves of recipient animals were determined (n = 10/group).
Data shown in (A) are presented as mean ± SD.
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CD45.2+LSK cells, PTPMT1 deletion in CD45.2+ lineage cells
was barely detected, suggesting that these lineage cells were
derived from PTPMT1-undeleted test cells. Remarkably, in
both competitive repopulation assay setups, the percentages
of CD45.2+LSK cells derived from PTPMT1-depleted test cells
were still four to six times greater than those in control test-
cell-derived populations in primary recipients (Figures 3G and
S3E), reaffirming the profound cell-autonomous effects of
PTPMT1 deficiency on stem/early progenitor cell homeostasis.
Catalytic Activity and Mitochondrial Localization Are
Required for the Function of PTPMT1 in HSCs
PTPMT1 is a phosphatase that is exclusively localized to the
mitochondria (Pagliarini et al., 2005). To elucidate the structural
bases for the indispensable role of PTPMT1 in HSCs, WT
PTPMT1, catalytically deficient PTPMT1 C132S, and truncated
PTPMT1 lacking the mitochondrial localization signal (amino
acids 1-37) (PTPMT1 D37) were transduced into PTPMT1fl/fl/
Mx1-Cre+ BM cells through retroviral-mediated gene transfer.
Transduced cells were sorted according to green fluorescent
protein (GFP) expressed separately by the retroviral vector,
and then assessed for repopulating/differentiation capabilities
by competitive repopulation assays, as described in Figure 3D.
Following deletion of endogenous PTPMT1 by pI-pC treatment,
control-vector-transduced PTPMT1fl/fl/Mx1-Cre+ cells failed to
reconstitute hematopoiesis (Figure 4A), consistent with the
results shown in Figures 3C and 3D. Reintroduction of WT
PTPMT1 in PTPMT1 knockout cells effectively rescued stem
cell repopulating capabilities. In contrast, neither PTPMT1
C132S nor PTPMT1 D37 exhibited any rescue capacity (Fig-
ure 4A). In addition, embryonic day 15.5 (E15.5) fetal liver hema-
topoietic cells isolated from PTPMT1fl/fl/Vav1-Cre+ embryos
were transduced with either WT PTPMT1, PTPMT1 C132S,
PTPMT1 D37, or control vector, and then assessed for radiopro-
tective function in lethally irradiated recipient mice. As shown in
Figure 4B, only WT PTPMT1-transduced knockout cells rescued
recipient animals, whereas all transplants receiving either
PTPMT1 C132S, PTPMT1 D37, or control-vector-transduced
knockout cells invariably died within 2–3 weeks of irradiation.Furthermore, the percentage of HSCs in WT PTPMT1-rescued
recipients was restored to the normal range (data not shown).
These add-back experiments, while confirming the crucial cell-
intrinsic role of PTPMT1 in HSCs, suggest that this phosphatase
functions in a catalytically dependent manner and that the mito-
chondrial localization is required for its function.
Depletion of PTPMT1 from Lineage Progenitors Does
Not Cause Any Defects in Lineage-Specific Knockout
Mice
To test whether PTPMT1 is generally important for all hemato-
poietic cells, we generated lineage-specific knockout mice
PTPMT1fl/fl/LysM-Cre+ (in granulocyte-macrophage progeni-
tors, GMPs), PTPMT1fl/fl/LCK-Cre+ (in CD4/CD8 stage T
lymphoid progenitors), and PTPMT1fl/fl/CD19-Cre+ (in pro-B
stage B lymphoid progenitors) mice by crossing PTPMT1fl/+
mice with LysM-Cre, LCK-Cre, and CD19-Cre transgenic mice,
respectively. Intriguingly, ablation of PTPMT1 from GMPs, T
lymphoid, or B lymphoid progenitors in these mice did not
disrupt normal cell development. In sharp contrast to panhema-
topoietic cell (including stem cell) knockouts (PTPMT1fl/fl/Vav1-
Cre+) that died at the postnatal stage, PTPMT1fl/fl/LysM-Cre+,
PTPMT1fl/fl/LCK-Cre+, and PTPMT1fl/fl/CD19-Cre+mice showed
no defects in myeloid, T lymphoid, or B lymphoid lineages
(Figures S4A–S4C), nor was the cell cycle of lineage progenitors
altered (Figure S4D). The lineage-specific knockout mice were
active and fertile without any discernible abnormalities during
the 1.5 years of follow-up. These in vivo data strongly suggest
that while PTPMT1 plays a vital role in stem cells, it is dispens-
able for late lineage progenitors.
PTPMT1-Depleted HSCs Are Accumulated at the G1
Phase in the Cell Cycle
To further define the underlying mechanisms for the differentia-
tion block of PTPMT1-depleted HSCs, we first tested whether
knockout HSCs were replicatively senescent by examining
senescence-associated beta-galactosidase (b-gal) activity
using 5-dodecanoylaminofluorescein di-b-D-galactopyranoside
(C12FDG), a fluorogenic substrate for b-gal. No significant differ-
ences in b-gal activities were detected in the HSCs of PTPMT1Cell Stem Cell 12, 62–74, January 3, 2013 ª2013 Elsevier Inc. 67
Figure 5. PTPMT1-Depleted HSCs Are Delayed at the G1 Phase of the Cell Cycle
(A andB) BMcells freshly harvested fromPTPMT1fl/fl/Mx1-Cre+ andPTPMT1+/+/Mx1-Cre+mice 4weeks following pI-pC treatmentwere assayed to determine the
cell cycle status of LSK cells (A, n = 9/group) and HSCs (B, n = 8/group). Percentages of LSK cells (A) and HSCs (B) at G0, G1, and S/G2/M phases were quantified.
(C and D) PTPMT1fl/fl/Mx1-Cre+ and PTPMT1+/+/Mx1-Cre+ mice (n = 5/group) were injected i.p. with BrdU (1.0 mg/6.0 g body weight) 4 weeks following pI-pC
treatment. Mice were sacrificed 16 hr later. BM cells were isolated and stained with antibodies against the indicated cell surface markers. BrdU staining was
performed using the FTIC BrdU Flow Kit (BD Biosciences). Cells were then stained with the DNA dye 7-amino-actinomycin D (7-AAD) and subjected to FACS
analyses so that percentages of BrdU+ cells in the LSK (C) and HSC (D) populations could be determined.
(legend continued on next page)
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of p16, a molecular hallmark of cellular senescence. Again, there
were no significant changes in p16 levels between WT and
knockout LSK cells (Figure 5F) or HSCs (Figure S4F). We then
analyzed the cell cycle status of LSK cells andHSCs. These anal-
yses revealed a significant increase in the percentages of
knockout LSK cells and HSCs at the G1 phase while the percent-
ages of S/G2/M cells were not changed (Figures 5A and 5B).
Moreover, the percentages of LSK cells and HSCs at the G0
phase (quiescence) were decreased in PTPMT1-depleted
mice. In vivo BrdU incorporation assays showed that after
16 hr of in vivo BrdU labeling, the percentages of BrdU+ cells
in LSK and HSC populations in PTPMT1 knockout mice were
not significantly altered (Figures 5C and 5D), verifying the S
phase data obtained from the dye-based cell cycle analyses
(Figures 5A and 5B). Furthermore, BrdU long-term label-retain-
ing assays (Wilson et al., 2008) demonstrated that BrdU label-re-
taining cells in the HSC population in PTPMT1 knockout mice
100 days after the BrdU labeling were markedly decreased (Fig-
ure 5E), reaffirming the loss of quiescence in PTPMT1 deficient
HSCs. Collectively, these cell cycle data suggest an enhanced
entry of quiescent stem cells (G0 phase) into the cell cycle in
PTPMT1 knockout mice, and that these cells were subsequently
delayed at the G1 phase (the ratio of S/G2/M cells to G1 cells was
decreased). In agreement with the cell cycle changes, p21 and
p57, cyclin-dependent kinase inhibitors critical for controlling
HSC cycling (Cheng et al., 2000; Matsumoto et al., 2011; Zou
et al., 2011), were significantly upregulated in PTPMT1-depleted
stem cells and early progenitors (Figure 5F).
PTPMT1 Depletion Results in Defective Mitochondrial
Aerobic Metabolism
Wenext sought to determine the fundamental impact ofPTPMT1
ablation on the mitochondria. Ultra structures of mitochondria in
PTPMT1-depleted stem cells were not altered (data not shown)
and the overall mitochondrial DNA content in these cells was
comparable to that in control cells (Figure 6A). Also, steady state
total cellular ATP levels (Figure 6B) and ROS levels in PTPMT1-
depleted HSCs (Figure 6C) were not significantly changed. We
next analyzed mitochondrial aerobic metabolism in intact, viable
LSK cells using real-time measurement of oxygen consumption.
PTPMT1 knockout cells had much lower basal oxygen con-
sumption and maximal oxidative capacity as compared with
WT cells (Figure 6D). Interestingly, measurement of extracellular
proton flux revealed that PTPMT1-depleted cells had signifi-
cantly increased extracellular acidification rates (Figure 6E),
suggesting that these cells exhibited enhanced glycolysis. In
agreement with these data on the mitochondrial function,
AMP-activated kinase (AMPK), an intracellular energy sensor
(Hardie, 2011), was highly activated (determined by phosphory-
lation of Thr172) in PTPMT1 knockout LSK cells (Figure 6F) and
HSCs (Figure 6G). Acetyl-CoA carboxylase (ACC), one of the(E)PTPMT1fl/fl/Mx1-Cre+ andPTPMT1+/+/Mx1-Cre+mice (n = 5/group) were inject
The mice were fed with BrdU (1.0 mg/ml) containing water for 10 days and sacr
BrdU+ cells in the HSC population as above.
(F) LSK cells, HSCs, and various subsets of phenotypic MPPs were sorted from
following pI-pC treatment. mRNA levels of the indicated cell cycle regulatory gen
Data shown in all panels are presented as mean ± SD. Also see Figure S4.targets of AMPK and a negative regulator of fatty acid oxidation
(Viollet et al., 2009), was inhibited, as evidenced by the increase
in the inhibitory phosphorylation of this enzyme (Figure 6F),
implying that fatty acid metabolism might be enhanced in
PTPMT1 knockout stem cells. Intriguingly, PTPMT1-depleted
macrophages derived from myeloid-specific knockout
(PTPMT1+/+/LysM-Cre+) mice also showed decreased mito-
chondrial aerobic metabolism at basal levels and maximal
reserve capacities (Figure S5A). However, no defects in the
growth (Figure S5B) and the cell cycle (Figure S5C) were de-
tected. Also, there was no upregulation of p53, p21, or p57 in
these knockout macrophages (Figure S5D), and AMPK phos-
phorylation was only marginally increased in these cells
(Figure S5E).
Excessive PIP Substrates of PTPMT1 Decrease
Mitochondrial Aerobic by Enhancing UCP2 Activity
PTPMT1 favors phosphatidylinositol phosphates (PIPs), espe-
cially PI(3,5)P2, PI5P, and PI(3,4)P2, as substrates (Shen et al.,
2011), similar to PTEN phosphatase. PIPs are a class of
membrane phospholipids that regulate many important cellular
processes, including membrane trafficking and ion channel/
transporter functions (Di Paolo and De Camilli, 2006; Gamper
and Shapiro, 2007). PTPMT1 is localized to the mitochondrial
inner membrane (Pagliarini et al., 2005) where many ion chan-
nels/transporters, important for mitochondrial metabolism,
reside. To determine the mechanisms of the altered mitochon-
drial function in PTPMT1-deficient cells, we assessed effects
of overloading these PIP substrates on mitochondrial aerobic
metabolism. Perfusion of PI(3,5)P2, PI(3,4)P2, or PI5P into WT
LSK cells resulted in a significant reduction in oxygen consump-
tion both at the basal level and at the maximal oxidative capacity
(Figures 7A and 7B), recapitulating the metabolic changes of
PTPMT1 knockout LSK cells (Figure 6D). These results indicate
that PIP substrates accumulated due to the loss of dephosphor-
ylation by PTPMT1 might account for the altered mitochondrial
function in PTPMT1-depleted cells.
We next sought to identify direct effector proteins of these
PIPs. A recent study has shown that ectopic expression of mito-
chondrial UCP2 blocks ESC differentiation with no impact on cell
survival (Zhang et al., 2011b). Enhanced UCP2 activity impairs
ESC differentiation by perturbing the metabolic transition from
glycolysis to mitochondrial aerobic metabolism required for
ESC differentiation (Zhang et al., 2011b). PTPMT1 depletion
also blocks ESC differentiation without affecting cell survival
(Shen et al., 2011). Similar effects caused by ectopic expression
of UCP2 andPTPMT1 ablation prompted us to test for a potential
link between PTPMT1 and UCP2. No differences in UCP2mRNA
levels were detected between WT and PTPMT1-depleted HSCs
(data not shown). We then tested whether PTPMT1 PIP
substrates might function as modulators of UCP2 activity using
a UCP2-reconstituted planar lipid bilayer system. As shown ined i.p. with BrdU (1.0mg/6.0 g body weight) 4 weeks following pI-pC treatment.
ificed 100 days later. BM cells were isolated and assessed for percentages of
PTPMT1fl/fl/Mx1-Cre+ and PTPMT1+/+/Mx1-Cre+ mice (n = 3/group) 4 weeks
es in these cells were determined by quantitative RT-PCR.
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Figure 6. Mitochondrial Aerobic Metabolism Is Defective in PTPMT1-Depleted LSK Cells
BM cells were freshly harvested from PTPMT1fl/fl/Mx1-Cre+ and PTPMT1+/+/Mx1-Cre+ mice (n = 4 or 5/group) 4 weeks following pI-pC treatment. HSCs were
sorted.
(A) Total DNA was extracted. Mitochondrial number was estimated by comparing mtDNA (Cytochrome B) levels to genomic DNA levels by quantitative PCR.
(B) Total cellular ATP levels were determined using an ATP assay kit.
(C) BM cells were immunostained with the antibodies recognizing HSCmarkers. Cells were then loaded with 20-70-dichlorofluorescein diacetate (DCF-DA) (5 mM)
for 15 min. Mean fluorescence intensity in the gated HSC population was quantified by FACS to determine ROS (H2O2) levels.
(D and E) LSK cells were sorted from PTPMT1fl/fl/Mx1-Cre+ and PTPMT1+/+/Mx1-Cre+ mice (n = 3 or 4/group) 4 weeks following pI-pC treatment. Oxygen
consumption rates (OCR) (D) and extracellular acidification rates (ECAR) (E) of live LSK cells were measured in the presence of the mitochondrial inhibitor
(oligomycin, 350 nM), the uncoupling agent (FCCP, 5 mM), and the respiratory chain inhibitor (rotenone, 1 mM). **p < 0.01.
(F) Whole-cell lysates of sorted LSK cells were prepared and examined by immunoblotting with anti-phospho-AMPK, anti-phospho-ACC, and anti-UCP2
antibodies. Each lane represents an individual cell pool. Representative results from three independent experiments are shown.
(G) BM cells freshly harvested from PTPMT1fl/fl/Mx1-Cre+ and PTPMT1+/+/Mx1-Cre+ mice (n = 5/group) 4 weeks following pI-pC treatment were immunostained
with antibodies recognizing HSC markers. Cells were then fixed, permeablized using the BD Cytofix/Cytoperm kit (BD Biosciences), and immunostained with
anti-phospho-AMPK (Thr172) antibody (Cell Signaling Technology). Mean fluorescence intensity in the gated HSC population was quantified and normalized by
FACS to determine phospho-AMPK levels. Light and dark gray lines indicate isotype controls.
Data shown in (A)–(E) and (G) are presented as mean ± SD. Also see Figure S5.
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Figure 7. Excessive PIP Substrates of PTPMT1 Decrease Aerobic Metabolism by Enhancing UCP2 Activity
(A and B) PI(3,5)P2, PI5P, and PI(3,4)P2 (di-C16) (20 mM)were delivered (shuttled) into purifiedWT LSK cells using Shuttle PIP kits (Echelon Biosciences, Inc.). Cells
were assessed for OCR. A representative figure is shown in (A) and statistical data are shown in (B). **p < 0.01.
(C) Representative current-voltage characteristics of UCP2-containing membranes measured in the presence of PI(3,5)P2, arachidonic acid (AA), or both. Bilayer
lipid membranes were made from E. coli polar lipid (1.8 mg/ml), AA (15 mol%), and hUCP2 (5 mg/mg lipid). Buffer solution contained 50mMNa2S04, 10 mM TRIS,
10 mM MES, and 0.6 mM EGTA (pH = 7.35), T = 32.
(D) Comparison of membrane conductance in the absence or presence of PI(3,5)P2, PI5P, or PI(3,4)P2. All PIPs were added at 4 mM. Statistical data from three
independent experiments are shown.
(E) HSCs purified from PTPMT1fl/fl/Mx1-Cre+ mice 4 weeks after pI-pC treatment were cultured in SCF (50 ng/ml), IL-3 (25 ng/ml), and IL-6 (20 ng/ml) containing
medium in the presence of PIKfyve inhibitor (YM201636) or DMSO (vehicle) for 7 days, immunostained for Mac-1 and B220, and then analyzed by FACS.
Statistical data from three independent experiments are shown.
(F) Sorted HSCs were assessed by the CFU assay in the presence of PIKfyve inhibitor (1 mM) or DMSO. Twelve days later, colonies derived were counted and
genotyped individually.
Data shown are mean ± SD of three independent experiments. Data shown in (A), (B), and (D)–(F) are presented as mean ± SD.
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but not their precursor PI, enhanced fatty acid (arachidonic
acid)-induced activation of UCP2. Total membrane proton
conductance carried out by UCP2 was markedly increased by
the addition of PI(3,5)P2, PI5P, and PI(3,4)P2. These in vitro
electrophysiological data provide direct evidence that PIP
substrates, which accumulate in PTPMT1-depleted mito-
chondria, can alter mitochondrial function by enhancing UCP
activities.
Finally, we reasoned that if excessive PIP substrates of
PTPMT1, such as PI(3,5)P2, contributed to the mitochondrial
dysfunction and thus the impaired differentiation of PTPMT1
knockout HSCs, then inhibition of PI(3,5)P2 production would
partially correct this problem. We treated purified PTPMT1
knockout HSCs with YM201636, a selective inhibitor of type III
PIP kinase PIKfyve (Jefferies et al., 2008) that is responsible for
the production of PI(3,5)P2. Indeed, cytokine-induced differenti-
ation of PTPMT1 knockout HSCs toward Mac-1+ cells was
largely restored in liquid culture by the PIKfyve inhibitor (Fig-
ure 7E). Moreover, cytokine-induced colony formation of
PTPMT1 knockout HSCs was also partially rescued (Figure 7F).
Approximately 50% of the colonies formed in the YM201636-
treated group were derived from PTPMT1-depleted HSCs while
none of the colonies seen in the DMSO-treated group were
generated from PTPMT1-deleted stem cells (they were derived
from residual PTPMT1-undeleted cells) according to PCR geno-
typing results (data not shown). These rescue data provide
further support to the notion that the differentiation block of
PTPMT1 knockout stem cells is likely attributed to the accumu-
lation of PTPMT1 PIP substrates.
DISCUSSION
By dissecting the role of mitochondrial phosphatase PTPMT1 in
hematopoiesis, this study has revealed an essential mitochon-
drial metabolic regulation of HSC differentiation. HSCs contain
similar numbers of mitochondria, as do myeloid progenitors
(Norddahl et al., 2011). However, stem cells utilize glycolysis
instead of aerobic metabolism for energy production (Simsek
et al., 2010), suggesting that mitochondria are less active in
these cells. In contrast, mitochondrial activities and ATP levels
are much higher in lineage progenitors (Inoue et al., 2010; Sim-
sek et al., 2010), indicating a robust upregulation of mitochon-
drial bioenergetics during stem cell differentiation. We now
provide evidence that PTPMT1 plays a critical role in priming
mitochondria for this rapid metabolic transition. PTPMT1 deple-
tion caused hematopoietic failure in mice (Figures 1B, S1D, 2A,
and 2B) and PTPMT1-depleted HSCs failed to differentiate in
both in vitro (Figures 3A, 3B, and S3A) and in vivo (Figures 3C,
3D, S3B, and S3C) settings. This appears to be attributed to
the alterations of mitochondrial metabolism in these cells (Fig-
ure 6D). Although steady state cellular ATP homeostasis was
maintained in knockout stem cells (Figure 6B), this was likely
due to a compensatory increase in alternative energy production
pathways. Indeed, extracellular acidification rates, an indication
of glycolysis, were elevated inPTPMT1-depleted cells (Figure 6E)
and the activity of ACC, a negative regulator of fatty acid oxida-
tion (Viollet et al., 2009), was inhibited (Figure 6F). Interestingly,
PTPMT1 regulation of mitochondrial bioenergetics appears to72 Cell Stem Cell 12, 62–74, January 3, 2013 ª2013 Elsevier Inc.be selectively important for differentiation versus self-renewal
in stem cells. Differentiation of PTPMT1 knockout HSCs was
completely blocked (Figure 3), but these cells were still cycling
in vivo. Although knockout stem cells were delayed at the G1
phase, the percentage of S/G2/M cells was comparable to that
of control cells. In addition, knockout stem cells lost quiescence
(G0 phase) (Figure 5). Since the stem cell pool in knockout mice
was drastically expanded (Figures 1G and 2E), these cell cycle
changes caused by PTPMT1 ablation appear to mainly impact
the differentiation-associated cycling while the cycling for stem
cell self-renewal was less affected (PTPMT1-depleted HSCs
failed to expand in vitro, likely because the culture condi-
tions—cytokines, nutrients, oxidative stress, etc.—were not
favorable). The underlying mechanism for this bias remains to
be further determined.
Equally interesting is that PTPMT1 is required for the differen-
tiation of stem cells and early progenitors but is not required for
late lineage progenitor differentiation. While panhematopoietic
cell (including stem cell) PTPMT1 knockout (PTPMT1fl/fl/Vav1-
Cre+) mice died postnatally of the differentiation arrest of HSCs
and early progenitors (Figures 2A and 2B), more restricted
myeloid, T lymphoid, or B lymphoid lineage-specific PTPMT1
knockout mice did not show any abnormalities (Figures S4A–
S4D). This suggests that PTPMT1 depletion has distinct effects
in hematopoietic cells depending on the stage in which the cells
are targeted. There appears to be a unique and specific require-
ment for mitochondrial energy metabolism for stem cell/early
progenitor differentiation that does not exist in late lineage
restricted progenitors or mature cells. Our previous studies
showed that the loss of PTPMT1 also blocked ESC differentia-
tion without impacting the function of mature embryonic
fibroblasts (Shen et al., 2011). It seems that the bioenergetic
stress-activated differentiation-controlling mechanism is well
conserved between embryonic and somatic stem cells. Similar
toHSCdifferentiation, ESCdifferentiation also requires a tremen-
dous energy supply, which relies on a robust and rapid upregu-
lation of mitochondrial activities. Unlike HSCs, however, ESCs
also require substantial mitochondrial biogenesis for differentia-
tion because the mitochondrial mass in ESCs is significantly
lower than that in differentiated cells (Cho et al., 2006; Lonergan
et al., 2007).
Another interesting finding in this report is that although mito-
chondrial metabolism in PTPMT1-depleted stem cells was only
moderately perturbed, the cellular responses (cell cycle changes
and differentiation block) were rather profound. This phenom-
enon is reminiscent of conditions involving nuclear DNA
damage, or mitotic spindle assembly checkpoints, in which
a single double-strand DNA break or misalignment of a single
chromosome causes complete cell cycle arrest (Musacchio
and Salmon, 2007; Reinhardt and Yaffe, 2009). The mitochon-
drial bioenergetic stress signal elicited by PTPMT1 ablation
appears to be propagated and amplified through the p53-p21/
p57 pathway, similar to the DNA-damage-induced cell cycle
checkpoint. Cyclin-dependent kinase inhibitors, p21 and p57,
were significantly upregulated, and p53 wasmoderately upregu-
lated in PTPMT1 knockout stem cells and early progenitors (Fig-
ure 5F). As the energy stress sensor AMPK was highly activated
in these cells (Figures 6F and 6G) and activation of AMPK has
been demonstrated to induce p53-dependent cell cycle arrest
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altered mitochondrial metabolism caused by PTPMT1 defi-
ciency is sensed by AMPK and then relayed to the p53-p21/
p57 pathway.
PTPMT1 deficiency appears to exert its deleterious effects by
disrupting PIP homeostasis in the mitochondria. PTPMT1 is
localized to the inner membrane (Pagliarini et al., 2005) and
breaks down PIPs (Pagliarini et al., 2004; Shen et al., 2011). Its
catalytic activity and mitochondrial localization were required
for HSC differentiation (Figure 4). Furthermore, overloading of
PIP substrates, such as PI(3,5)P2, in WT LSK cells decreased
mitochondrial oxygen consumption (Figure 7A), recapitulating
themetabolic changes seen in PTPMT1-depleted LSK cells (Fig-
ure 6D). In contrast, inhibition of PI(3,5)P2 production by the PIK-
fyve inhibitor partially restored differentiation capabilities of
PTPMT1 knockout HSCs (Figures 7E and 7F). More importantly,
PIP substrates of PTPMT1 directly enhanced fatty-acid-induced
activation of mitochondrial UCP2 in in vitro proteoliposome
assays (Figures 7C and 7D). Since UCP2 inhibits glucose-
derived pyruvate oxidation in mitochondria (Bouillaud, 2009;
Diano and Horvath, 2012; Samudio et al., 2009) and cellular
differentiation may be intimately tied to the balance between
glucose and fatty acid oxidation (Pearce et al., 2009; Zhang
et al., 2011b), one intriguing hypothesis is that the build-up of
PIP substrates in PTPMT1-depleted mitochondria enhances
UCP2 function and thereby critically alters mitochondrial
substrate utilization within the stem cell, leading to bioenergetic
stress and differentiation block. Further studies will be essential
to determine the structural bases of the interactions between
PIPs and UCP2, how PTPMT1 might regulate other aspects of
UCP-mediated physiology, and whether PTPMT1 plays a similar
role in other tissue-specific stem cells.
EXPERIMENTAL PROCEDURES
Apoptosis and Cellular ROS Level Measurement
Fresh BM cells were stained with biotin-labeled antibodies against lineage
markers (Gr-1, Mac-1, B220, Ter119, CD4, CD8, and CD3e) and then stained
with Streptavidin eFluor 450 and antibodies labeled with various fluoro-
chromes (anti-c-Kit-APC-Cy7, anti-Sca-1-PE-Cy7, anti-CD150-APC, and
anti-CD48-PE) purchased from BD Biosciences (San Jose, CA) or eBioscien-
ces, Inc. (San Diego, CA). The cells were then stained with Annexin V-FITC and
7-amino-actinomycin D (7-AAD) using an Annexin V-FITC apoptosis Detection
Kit I (BD Biosciences). Apoptotic cells in the gated HSC (LineageSca-1+c-
Kit+CD150+CD48) population were quantified by FACS. To measure cellular
ROS levels, cells were loaded with 20-70-dichlorofluorescein diacetate (DCF-
DA) (5 mM) at 37C for 15 min after being stained with the antibodies described
as above. ROS (H2O2) levels in the gated HSCpopulationwere quantified using
flow cytometry.
Cell Cycle Analysis
To analyze the cell cycle status of LSK cells, fresh BM cells were stained with
Pyronin Y (1 mg/ml) and Hoechst 33342 (10 mg/ml). The cells were washed and
then stained with antibodies labeled with various fluorochromes (anti-line-
ages-APC-Cy7 [Gr-1, Mac-1, B220, Ter119, CD4, CD8, and CD3e], anti-c-
Kit-APC, and anti-Scal-1-PE-Cy7). Subsequent cell population gating and
quantification of the cells at G0, G1, and S/G2/M phases by FACS were per-
formed as previously reported (Xu et al., 2011; Xu et al., 2010). For HSC cycle
analysis, HSCs (LineageSca-1+c-Kit+CD150+CD48) were sorted and
deposited into 75% ethanol. Cells were fixed at 20C for 24 hr and then
stained with FITC-labeled anti-Ki67 antibody (BD Biosciences) followed by
propidium iodide (PI) (50 mg/ml). Percentages of the cells at G0, G1, and S/
G2/M phases were quantified by FACS.Oxygen Consumption and ATP Measurement
Measurement of intact cellular respiration was performed using the Seahorse
XF24 and XF96 analyzers as previously described (Liu et al., 2009). Respiration
was measured under basal conditions, in the presence of mitochondrial
inhibitor oligomycin (350 nM), mitochondrial uncoupling compound carbonyl-
cyanide-4-trifluorometh-oxyphenylhydrazone (FCCP) (5 mM), and respiratory
chain inhibitor rotenone (1 mM). To determine total cellular ATP levels, live
HSCs (LineageSca-1+c-Kit+CD150+CD48) were sorted into PBS and
assessed using a CellTiter-Glo Luminescent Cell Viability Assay kit (Promega
Corporation, Madison, WI), which is a homogeneous method to determine the
number of viable cells in culture based on quantitation of the ATP present.
Reconstitution of UCP2 in Liposomes, Formation of UCP2-
Containing Planar Bilayer, and Proton Conductance Measurement
Human recombinant UCP2 was purified from E. coli inclusion bodies and re-
constituted into liposomes using a previously described protocol (Beck
et al., 2007; Rupprecht et al., 2010). To introduce arachidonic acid (AA) and/
or PIPs, proteoliposomes were mixed with AA- or PIP-containing liposomes
in required proportions. Planar lipid bilayers were formed from proteolipo-
somes on the tip of plastic pipettes as previously described (Beck et al.,
2006). Current-voltage (I-V) characteristics were measured by a patch-clamp
amplifier (EPC 10, HEKA Elektronik Dr. Schulze GmbH, Germany). Total
membrane conductance was determined from a linear fit of experimental
data (I) at applied voltages ranging from50 to 50 mV as described previously
(Rupprecht et al., 2010).
Statistical Analysis
Statistical significance was determined using unpaired two-tailed Student’s t
test. p < 0.05 was considered to be significant.
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